| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3'-5' RNA helicase activity | 1.50e-04 | 6 | 64 | 2 | GO:0034458 | |
| HumanPheno | Urethral stenosis | 1.76e-05 | 57 | 15 | 4 | HP:0008661 | |
| HumanPheno | Urethral obstruction | 3.76e-05 | 69 | 15 | 4 | HP:0000796 | |
| Domain | - | 1.39e-07 | 4 | 62 | 3 | 3.90.1460.10 | |
| Domain | GTF2I | 1.39e-07 | 4 | 62 | 3 | PS51139 | |
| Domain | GTF2I | 1.39e-07 | 4 | 62 | 3 | PF02946 | |
| Domain | GTF2I | 1.39e-07 | 4 | 62 | 3 | IPR004212 | |
| Domain | Tyr-prot_kinase_Fes/Fps | 1.08e-05 | 2 | 62 | 2 | IPR016250 | |
| Domain | FCH | 2.40e-03 | 22 | 62 | 2 | PF00611 | |
| Domain | FCH | 2.40e-03 | 22 | 62 | 2 | SM00055 | |
| Domain | FCH_dom | 2.62e-03 | 23 | 62 | 2 | IPR001060 | |
| Domain | F_BAR | 3.10e-03 | 25 | 62 | 2 | IPR031160 | |
| Domain | F_BAR | 3.10e-03 | 25 | 62 | 2 | PS51741 | |
| Domain | TyrKc | 3.13e-03 | 88 | 62 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.13e-03 | 88 | 62 | 3 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 4.11e-03 | 97 | 62 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.11e-03 | 97 | 62 | 3 | IPR008266 | |
| Domain | SH2 | 4.61e-03 | 101 | 62 | 3 | PF00017 | |
| Domain | SH2 | 5.84e-03 | 110 | 62 | 3 | SM00252 | |
| Domain | SH2 | 5.99e-03 | 111 | 62 | 3 | PS50001 | |
| Domain | SH2 | 6.14e-03 | 112 | 62 | 3 | IPR000980 | |
| Domain | - | 6.14e-03 | 112 | 62 | 3 | 3.30.505.10 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 17823943 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 23229069 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 22899722 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 21328569 | ||
| Pubmed | GMPS CAND1 GTF2I ADRM1 CLIC1 KMT2A NBN VIRMA HNRNPLL RNF138 AQR | 2.22e-06 | 1014 | 64 | 11 | 32416067 | |
| Pubmed | Fer kinase limits neutrophil chemotaxis toward end target chemoattractants. | 3.33e-06 | 2 | 64 | 2 | 23355730 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12871378 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11994747 | ||
| Pubmed | Fps/Fes and Fer protein-tyrosinekinases play redundant roles in regulating hematopoiesis. | 3.33e-06 | 2 | 64 | 2 | 12901971 | |
| Pubmed | FER and FES tyrosine kinase fusions in follicular T-cell lymphoma. | 3.33e-06 | 2 | 64 | 2 | 31746983 | |
| Pubmed | KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway. | 3.33e-06 | 2 | 64 | 2 | 28726783 | |
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 3.33e-06 | 2 | 64 | 2 | 15388857 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11110714 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 7.58e-06 | 934 | 64 | 10 | 33916271 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18053124 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 15100712 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GMPS FLNA CAND1 GTF2I ADRM1 NUP210 LAMB1 YTHDC2 ADGRL2 HNRNPLL | 1.09e-05 | 974 | 64 | 10 | 28675297 |
| Pubmed | Amino- and carboxyl-terminal domains of Filamin-A interact with CRMP1 to mediate Sema3A signalling. | 2.00e-05 | 4 | 64 | 2 | 25358863 | |
| Pubmed | 2.60e-05 | 653 | 64 | 8 | 22586326 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 2.95e-05 | 665 | 64 | 8 | 30457570 | |
| Pubmed | 3.38e-05 | 199 | 64 | 5 | 36688959 | ||
| Pubmed | 3.52e-05 | 334 | 64 | 6 | 30425250 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 15322554 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 16731527 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 26702831 | ||
| Pubmed | PRPSAP1 PALD1 FLNA CAND1 GTF2I CLIC1 NUP210 LAMB1 KMT2A YTHDC2 ADGRL2 | 5.83e-05 | 1440 | 64 | 11 | 30833792 | |
| Pubmed | 6.96e-05 | 7 | 64 | 2 | 12192036 | ||
| Pubmed | 7.29e-05 | 234 | 64 | 5 | 36243803 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 1.31e-04 | 265 | 64 | 5 | 19240061 | |
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 1.36e-04 | 141 | 64 | 4 | 32322062 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.45e-04 | 271 | 64 | 5 | 32433965 | |
| Pubmed | Expression of tyrosine kinase gene in mouse thymic stromal cells. | 1.49e-04 | 10 | 64 | 2 | 8943574 | |
| Pubmed | 2.13e-04 | 464 | 64 | 6 | 32457219 | ||
| Pubmed | Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. | 2.17e-04 | 12 | 64 | 2 | 21743467 | |
| Pubmed | 2.79e-04 | 170 | 64 | 4 | 36470425 | ||
| Pubmed | FLNA GTF2IRD2B BBX GUCY1A2 RGPD1 GTF2IRD2 KMT2A REL CADPS2 NARS2 | 2.86e-04 | 1442 | 64 | 10 | 35575683 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 3.08e-04 | 1455 | 64 | 10 | 22863883 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 3.39e-04 | 179 | 64 | 4 | 36261009 | |
| Pubmed | 3.45e-04 | 15 | 64 | 2 | 14697343 | ||
| Pubmed | 3.85e-04 | 1497 | 64 | 10 | 31527615 | ||
| Pubmed | 3.94e-04 | 77 | 64 | 3 | 22973453 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 4.35e-04 | 344 | 64 | 5 | 30333137 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 4.71e-04 | 1257 | 64 | 9 | 36526897 | |
| Pubmed | 4.92e-04 | 83 | 64 | 3 | 11114734 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 5.00e-04 | 1005 | 64 | 8 | 19615732 | |
| Pubmed | 5.34e-04 | 202 | 64 | 4 | 24639526 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.44e-04 | 774 | 64 | 7 | 15302935 | |
| Pubmed | 5.59e-04 | 19 | 64 | 2 | 19490896 | ||
| Pubmed | Transcriptional fates of human-specific segmental duplications in brain. | 5.59e-04 | 19 | 64 | 2 | 30228200 | |
| Pubmed | 6.18e-04 | 210 | 64 | 4 | 16565220 | ||
| Pubmed | A novel common variant in DCST2 is associated with length in early life and height in adulthood. | 6.20e-04 | 20 | 64 | 2 | 25281659 | |
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 6.23e-04 | 90 | 64 | 3 | 16273093 | |
| Pubmed | 6.23e-04 | 90 | 64 | 3 | 28978906 | ||
| Pubmed | 6.95e-04 | 1327 | 64 | 9 | 32694731 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 7.05e-04 | 582 | 64 | 6 | 20467437 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 7.23e-04 | 219 | 64 | 4 | 31353912 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 8.58e-04 | 400 | 64 | 5 | 35013556 | |
| Pubmed | 8.77e-04 | 402 | 64 | 5 | 24722188 | ||
| Pubmed | 9.10e-04 | 233 | 64 | 4 | 37704626 | ||
| Pubmed | 9.16e-04 | 1103 | 64 | 8 | 34189442 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 9.40e-04 | 235 | 64 | 4 | 30258100 | |
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 9.73e-04 | 25 | 64 | 2 | 15254900 | |
| Pubmed | Genome-wide association study identifies multiple loci associated with bladder cancer risk. | 1.05e-03 | 26 | 64 | 2 | 24163127 | |
| Pubmed | 1.05e-03 | 26 | 64 | 2 | 23382103 | ||
| Pubmed | Genome-wide association identifies multiple ulcerative colitis susceptibility loci. | 1.05e-03 | 26 | 64 | 2 | 20228799 | |
| Pubmed | Pooled-matrix protein interaction screens using Barcode Fusion Genetics. | 1.05e-03 | 419 | 64 | 5 | 27107012 | |
| Pubmed | Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination. | 1.14e-03 | 27 | 64 | 2 | 30442762 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 1.19e-03 | 431 | 64 | 5 | 33660365 | |
| Pubmed | Novel interactors and a role for supervillin in early cytokinesis. | 1.22e-03 | 28 | 64 | 2 | 20309963 | |
| Pubmed | 1.27e-03 | 652 | 64 | 6 | 31180492 | ||
| Pubmed | 1.30e-03 | 116 | 64 | 3 | 21282530 | ||
| Pubmed | 1.32e-03 | 657 | 64 | 6 | 36180527 | ||
| Pubmed | 1.32e-03 | 1168 | 64 | 8 | 19946888 | ||
| Pubmed | 1.50e-03 | 31 | 64 | 2 | 31901637 | ||
| Pubmed | A high-resolution radiation hybrid map of the proximal portion of mouse chromosome 5. | 1.70e-03 | 33 | 64 | 2 | 10843805 | |
| Interaction | GTF2IRD2 interactions | 6.28e-06 | 12 | 63 | 3 | int:GTF2IRD2 | |
| Interaction | GTF2IRD2B interactions | 1.29e-05 | 15 | 63 | 3 | int:GTF2IRD2B | |
| Cytoband | 7q11.23 | 3.47e-04 | 97 | 64 | 3 | 7q11.23 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 1.17e-03 | 23 | 40 | 2 | 1288 | |
| GeneFamily | SH2 domain containing | 1.44e-03 | 101 | 40 | 3 | 741 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 173 | 64 | 5 | e4eb2ac2cee16bfa8eabc938f8030ee161c972c5 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 173 | 64 | 5 | 371515471459307a3b2adce735263b4aac828956 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 173 | 64 | 5 | 4e9b6c71030ae0d63d54e7255e4a10b25970fcc4 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.47e-06 | 176 | 64 | 5 | 218a072882d387adbbad6916d7214099c7354465 | |
| ToppCell | COVID-19_Mild-CD8+_Tem|COVID-19_Mild / Disease condition and Cell class | 9.93e-06 | 199 | 64 | 5 | 9016fbe5fe55e1ffa279ee8e8db3c93b5cf914d5 | |
| ToppCell | COVID-19_Mild-NK|COVID-19_Mild / Disease condition and Cell class | 1.02e-05 | 200 | 64 | 5 | b586b0f1127293c2f8529be16b24229359041da2 | |
| ToppCell | droplet-Heart-4Chambers-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 149 | 64 | 4 | 38890ddde0979977c8350f01497f1245ab51641a | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-05 | 153 | 64 | 4 | cb144b8c487286384b47fdff88ff98fcf0508899 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.70e-05 | 157 | 64 | 4 | c3451b33780499fd62672e7cd71c7e8cb6ccc2c5 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.70e-05 | 157 | 64 | 4 | 92cd58b62e46b93f90e05657fd201404ccae6ddb | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.70e-05 | 157 | 64 | 4 | 042129d1b514dc4ed8a5f45b52d9c73cf4807636 | |
| ToppCell | E17.5-Hematopoietic-Immune-immune_cell_unspecified|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.49e-05 | 161 | 64 | 4 | 30741ca6548db2dfb5cf1faecf0d7412c91d0077 | |
| ToppCell | E17.5-Hematopoietic-Immune|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.49e-05 | 161 | 64 | 4 | e3ff08d0b9c686253556c56ee88648206751ef2b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.78e-05 | 167 | 64 | 4 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 169 | 64 | 4 | d4a0bd792bddfa34332d7dc432ce253f50d98c6f | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-04 | 169 | 64 | 4 | 1de3ae36d3b60e961bfd9f7bdc37867b82a0417f | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 170 | 64 | 4 | e4856e768d0088e42fbdb8e6039f5bc3daa0afdb | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 170 | 64 | 4 | d582087a983fe20d811d92f0de0458f3cfd71d2b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 170 | 64 | 4 | dfbe7ba11b867a4e10fa915f282a2e5cb2f5fb8c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Myeloid-new-cluster|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 171 | 64 | 4 | d0d92eb5152410c3b4dd4a3f1dc3cca0e18a85fd | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 171 | 64 | 4 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-mature_NK_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-04 | 171 | 64 | 4 | a0462781d22c391b3c6c8a72586c385ac089ca5d | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-04 | 171 | 64 | 4 | 85b655dc8a3cbf0e8097e951116490e326a795ac | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 171 | 64 | 4 | f12c2e48637b96557afbc2006a3a23ba21b7951e | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 171 | 64 | 4 | 12c98dea7370377695c5d22309f78ba03e282a0e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.10e-04 | 172 | 64 | 4 | b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 172 | 64 | 4 | c260680f5455fce133b7b4158b4197fc76115779 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-04 | 173 | 64 | 4 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.15e-04 | 174 | 64 | 4 | e324320b52c904496e26fcecfa179b3431729ec0 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 64 | 4 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 177 | 64 | 4 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 64 | 4 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 178 | 64 | 4 | 674ee5095b98929c29e4f6bd56029a336cc4a38c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.33e-04 | 181 | 64 | 4 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 181 | 64 | 4 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 184 | 64 | 4 | f9365feed31e48f3382588bab077f99c5a3f5b04 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 184 | 64 | 4 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-04 | 185 | 64 | 4 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | facs-Marrow|facs / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 64 | 4 | e40f0a0439834c3025d6c7832977be4e37a94c44 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 185 | 64 | 4 | 9878392d79734ab5bb977d7f4f5e2e079b9a5353 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 186 | 64 | 4 | ed265e52e4f9b6d277b489091ecc2e629436f791 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-04 | 188 | 64 | 4 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Tregs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.61e-04 | 190 | 64 | 4 | f69a4733b5d1542ab4d0eb44856f2c5c34c18b9e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-04 | 190 | 64 | 4 | 4498705c5c1c7ba88a26fd2f412cf1aadd0f572a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.61e-04 | 190 | 64 | 4 | 10125091ad648163777b02e9f0d5e8d7f17d44a5 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.64e-04 | 191 | 64 | 4 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.67e-04 | 192 | 64 | 4 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 193 | 64 | 4 | 371f4c98a599923fbe8382530b3eab05d873665a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 193 | 64 | 4 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 193 | 64 | 4 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.74e-04 | 194 | 64 | 4 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 64 | 4 | 158dc393639e69aecfb014f6106797214ea05fe5 | |
| ToppCell | ILEUM-inflamed-(6)_ILC3|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.77e-04 | 195 | 64 | 4 | c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-04 | 196 | 64 | 4 | ff88e5b919b1be93159ad2200a7786d1c5272724 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-04 | 197 | 64 | 4 | aec598543d9a6bd20670bc9855d6531a5ba995fa | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-04 | 197 | 64 | 4 | 340ce4fef244176fb52e38ffbcbdfda5ac3467dd | |
| ToppCell | tumor_Lung-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass | 1.84e-04 | 197 | 64 | 4 | e9fac2c923179b2b8b0500076421c6fb09960b56 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.84e-04 | 197 | 64 | 4 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.84e-04 | 197 | 64 | 4 | 54fb7197db3c0dc87a1114e1ab1d2bfafd564b35 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-04 | 197 | 64 | 4 | b6689a3e01e4c285fc2cb33f8c437078722a3892 | |
| ToppCell | ASK428-Immune|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.88e-04 | 198 | 64 | 4 | 777ee3e46943f8ec76ffc0f42be0e2658c0bd57f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-04 | 198 | 64 | 4 | a6b942fe850e287e1cb705684e29218072daf891 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.88e-04 | 198 | 64 | 4 | 72aad5b2dcd8b0bde58828fa4f8129fe6cb6a21d | |
| ToppCell | 390C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-04 | 198 | 64 | 4 | 36e49a4860b37d674511120b9e0366efa1e08480 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.88e-04 | 198 | 64 | 4 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-04 | 198 | 64 | 4 | ecd93e28bae4152467f6d6621cffc73c301c9795 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 199 | 64 | 4 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | CTRL-Myeloid|CTRL / Disease state, Lineage and Cell class | 1.92e-04 | 199 | 64 | 4 | 70b89a930709fdb91fde6f96106add8455b11618 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-04 | 199 | 64 | 4 | 5abfbccae147d399e4234f90ae5cd9529abe4dd1 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 199 | 64 | 4 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-04 | 199 | 64 | 4 | da7cf363712ecec4fb90e3881eb585b7eea13fe7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-04 | 199 | 64 | 4 | 81b3cb41abbee9785041170d0469edc50b622d7e | |
| ToppCell | 3'-Parenchyma_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-04 | 199 | 64 | 4 | bc064ccfec8c1e96079b89b05aeebddf48bc87f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-04 | 199 | 64 | 4 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-04 | 199 | 64 | 4 | 53dac0455b84597460457ed429969a42ed0fe932 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-04 | 199 | 64 | 4 | 3216fdaba8be8e8e715aceb2c29f1ad5cc02f8ae | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-04 | 199 | 64 | 4 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.95e-04 | 200 | 64 | 4 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.95e-04 | 200 | 64 | 4 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.95e-04 | 200 | 64 | 4 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.95e-04 | 200 | 64 | 4 | 8f585920bf7ad8bb489c78e2db42435962de4416 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.95e-04 | 200 | 64 | 4 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Control-Myeloid|Control / Condition, Lineage and Cell class | 1.95e-04 | 200 | 64 | 4 | 379f5de322beb7f8f8a58c1609c8f895f8285132 | |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.95e-04 | 200 | 64 | 4 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | proximal-mesenchymal-Pericyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.95e-04 | 200 | 64 | 4 | a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Sema3e-Excitatory_Neuron.Sc17a7.Sema3e-Nnat_(Layer_6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.67e-04 | 87 | 64 | 3 | 7518ca56d626619d9706505169a85f1850105608 | |
| ToppCell | Severe-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.36e-04 | 117 | 64 | 3 | b5c27f24272216fa9f9107f5d00f3077847bb7ed | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.84e-04 | 136 | 64 | 3 | 186be8e1595608004b8216892cb9c7a7f31fbb4d | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.84e-04 | 136 | 64 | 3 | feb957df4bff3266cb9a7382b16fc927ae03b9b4 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.00e-03 | 137 | 64 | 3 | a49ed8ab3da922e8b83a2497e48807e59be01c84 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.00e-03 | 137 | 64 | 3 | 0e7fbd2a4678e47a50b4b7cd5f76db954626b691 | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 1.07e-03 | 140 | 64 | 3 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-03 | 144 | 64 | 3 | 8bd042f12186f36bc5aabf6a0232270a448f4b58 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-03 | 144 | 64 | 3 | 75b16adfbe84f69376e6566d531ba7919d5c5192 | |
| ToppCell | IIH-CD8-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.21e-03 | 146 | 64 | 3 | 7fa6e35def3f7cffbee1e1c2f10b523bab678e14 | |
| ToppCell | PND01-03-samps-Myeloid-Granulocyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.28e-03 | 149 | 64 | 3 | 7bdb396de8a1ef27ab0c2aaf1452576f4b0b5561 | |
| ToppCell | PND01-03-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.28e-03 | 149 | 64 | 3 | 50f53018e525b3d252caa8bed9e075b1bb1086dd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-03 | 151 | 64 | 3 | 16fc903fc71e25717b9908416f0bcd29c0a65a61 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-03 | 151 | 64 | 3 | ced4f7ee377a23a804ae6fde624e8b55b79f1fd8 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-03 | 151 | 64 | 3 | b52bb3b88e9a6473f571053537b8beb418678539 | |
| Disease | Aplastic anemia | 4.61e-05 | 5 | 64 | 2 | cv:C0002874 | |
| Disease | APLASTIC ANEMIA | 4.61e-05 | 5 | 64 | 2 | 609135 | |
| Disease | lymphocyte percentage of leukocytes | 9.29e-05 | 665 | 64 | 8 | EFO_0007993 | |
| Disease | Aplastic Anemia | 9.66e-05 | 7 | 64 | 2 | C0002874 | |
| Disease | Hypoplastic anemia | 9.66e-05 | 7 | 64 | 2 | C0178416 | |
| Disease | Lymphoid leukemia | 1.29e-04 | 8 | 64 | 2 | C0023448 | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 1.29e-04 | 8 | 64 | 2 | EFO_0800533 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 4.17e-04 | 447 | 64 | 6 | EFO_0000694, MONDO_0100096 | |
| Disease | lingual gyrus volume measurement | 7.73e-04 | 19 | 64 | 2 | EFO_0010314 | |
| Disease | Kidney Diseases | 9.36e-04 | 88 | 64 | 3 | C0022658 | |
| Disease | mean platelet volume | 1.58e-03 | 1020 | 64 | 8 | EFO_0004584 | |
| Disease | Oral ulcer | 1.64e-03 | 107 | 64 | 3 | HP_0000155 | |
| Disease | Epileptic encephalopathy | 1.94e-03 | 30 | 64 | 2 | C0543888 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PQYSPVTFDRKCVPV | 701 | Q8WY36 | |
| FYCKSPVPLRPENVV | 151 | Q96QU6 | |
| VAGCREPQFIYPNII | 21 | Q9BYD9 | |
| VTALVRKFLGPVPVY | 301 | P17405 | |
| PYIFVCPGTLKAIVD | 131 | O95490 | |
| VCFLITVRPTKPYGT | 561 | O60306 | |
| YPGCKITVFDIPEVV | 201 | P46597 | |
| VVREEYFPPKVLCGV | 176 | P21730 | |
| VYTVVQPVGPRVLQC | 191 | P32239 | |
| KFPCPVQVFRVYGLH | 101 | Q8TC90 | |
| SFCKVYQKIILVPRP | 691 | Q86XH1 | |
| IAVDRFQCVVYPFKP | 241 | Q9Y5X5 | |
| YTVCNPVGKVQRIVI | 186 | Q8WVV9 | |
| IIPNKVAPVVITYNC | 51 | Q9ULE6 | |
| PLPRYGQVKPVRVCT | 856 | Q9HCC9 | |
| LCLVFPAPAKAVVYV | 961 | Q8TEM1 | |
| CVGRYPVCKFPSLQV | 496 | Q96JP0 | |
| YTAGVVLPKPVGTCR | 281 | P30419 | |
| VVRPIFTVCGTPTYV | 506 | Q9C098 | |
| VPPVVACVGDPFYKI | 521 | Q86VP6 | |
| SRYVVLPRPVCFEKG | 661 | P07942 | |
| LPRPVCFEKGTNYTV | 666 | P07942 | |
| GYKVYPTLRCPVFVV | 321 | Q6P988 | |
| PAIFTIGKPVLGICY | 91 | P49915 | |
| NVNRVVYIFGPPVKE | 556 | P49915 | |
| IYECPVYKTRIRGPT | 4421 | Q9UFH2 | |
| VKLIGVCTQRQPVYI | 621 | P16591 | |
| FYTAPQPGKYVICVR | 1711 | P21333 | |
| VCAPFYVGCKPPQIV | 136 | P82251 | |
| QPGKVVVFIKPTCPY | 11 | P35754 | |
| VVFIKPTCPYCRRAQ | 16 | P35754 | |
| IKNFYEGCVKPPTVI | 6 | A6NN92 | |
| VGIVLIIYFRKPCSG | 246 | P28067 | |
| VVRCIAYPFNAKQPT | 91 | Q86UW7 | |
| KFSGVYGPIICQRPS | 261 | Q6IQ26 | |
| KQVCGTPEYIAPEVI | 741 | O15021 | |
| VYTCKIVECRPPVVE | 2066 | Q03164 | |
| TACARNIIGVIPYFP | 86 | Q14558 | |
| SLVQVFCVIPKYIQP | 246 | Q5T1A1 | |
| FCVIPKYIQPFLRQT | 251 | Q5T1A1 | |
| VPYRKITFNPGCVVI | 356 | Q86UP8 | |
| VPYRKITFNPGCVVI | 356 | Q6EKJ0 | |
| IRPKCQVIYFPIRFP | 156 | Q4AE62 | |
| KVPYRKITINPGCVV | 891 | P78347 | |
| LKPGTVYFVQVRCNP | 301 | O75462 | |
| AAYEKRFPTCPQIPV | 21 | O43304 | |
| TIAGRINCPVYITKV | 241 | Q14194 | |
| CYVIAFQVPRPKIKL | 311 | P0DJD0 | |
| RLIGVCTQKQPIYIV | 621 | P07332 | |
| FPKEIPGICYFLEVR | 686 | P33402 | |
| KVLVPVAVYCGSIPR | 11 | Q6ZUX3 | |
| ICGRPIVKPEYFTEF | 166 | O60934 | |
| VKHCGNIPVFVINYP | 356 | Q96I59 | |
| FYCPVCQEVLKTPVR | 16 | Q8WVD3 | |
| EFKRVPQCPSGRVYV | 81 | Q16186 | |
| IVQVVCKKYRGFTIP | 186 | O00299 | |
| YECKQRSVVPSVVPV | 486 | Q8IYI8 | |
| VHRQVAIVFKTPPYC | 236 | Q04864 | |
| GVCIQRKPLYIVTEF | 331 | P42681 | |
| GSCPVIYIQGRPFEV | 361 | Q9H6S0 | |
| PQQICERYPIFVEKV | 286 | Q16401 | |
| VVIPCLIYRKTGFIG | 111 | Q2M3R5 | |
| PGPYVFCITEKGVVK | 131 | Q8NAP3 | |
| FPCVVYINEVRVIPP | 31 | Q69YN4 | |
| PKTVGYCIIPICLAV | 126 | Q8N6I4 | |
| FVYSPAPQGVTVRCR | 191 | O75386 | |
| VPEYGCVVNLRKTVV | 891 | O14746 | |
| VIVFYVQSRPPFKVL | 866 | Q5VV43 | |
| PVIYTRPGNTVKLNC | 2741 | Q9NR99 |